| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |




From the Departments of Microbiology and Oral Biology,*
Immunobiology Vaccine Center, University of Alabama at Birmingham
Medical Center, Birmingham, Alabama; the Department of Pediatrics
Division of Infectious Diseases
and the
Departments of Pathology
and
Otolaryngology,§
Vanderbilt University,
Nashville, Tennessee; and the Department of Mucosal
Immunology, Research Institute for Microbial
Diseases, Osaka University, Osaka, Japan
| Abstract |
|---|
|
|
|---|
65%), approximately 5% macrophages, and 30%
CD3+ T cells. The T cells were primarily of the
CD4+ subset (
80%). Tonsillar intraepithelial
lymphocytes were also enriched in B cells. The analysis of dispersed
cells revealed a higher frequency of cells secreting IgG than IgA and
the predominant Ig subclass profiles were IgG1 > IgG3 and
IgA1 > IgA2, respectively. In situ
analysis also revealed higher numbers of IgG- than IgA-positive cells.
These IgG-positive cells were present in the epithelium and in the
subepithelial zones of both tonsils and adenoids. Mitogen-triggered T
cells from tonsils and adenoids produced both Th1- and Th2-type
cytokines, clearly exhibiting their pluripotentiality for
support of cell-mediated and Ab responses. Interestingly,
antigen-specific T cells produced interferon-
and lower levels of
interleukin-5. These results suggest that adenoids and tonsils of the
nasopharyngeal-associated lymphoreticular tissues represent a distinct
component of the mucosal-associated lymphoreticular tissues with
features of both systemic and mucosal compartments.
| Introduction |
|---|
|
|
|---|
The question of whether removal of tonsils may compromise protection of the upper respiratory tract and result in humoral immunodeficiency has been the subject of debate.12-15 Combined adenoidectomy and tonsillectomy were reported to reduce IgA titers in nasopharyngeal secretions to poliovirus and to delay or abrogate the mucosal immune response to subsequent live poliovirus vaccine.16 This suggested a potential role for these lymphoid tissues in IgA responses and would support the notion that they are NALT. However, adenoids and tonsils were also reported to spontaneously produce lower levels of IgA than IgG.17 This is in marked contrast to the Ab isotypes associated with mucosal surfaces.18 Thus, although the tonsils contain the complete set of cellular components necessary for primary19 and secondary immune responses,20 the precise contribution of these lymphoid structures to induction and regulation of mucosal and systemic immune responses to inhaled or ingested antigens is still unclear. It is still open to debate whether adenoids and tonsils are sites for induction of immune responses or whether these tissues behave as effector sites for immune responses initiated in systemic or other mucosal compartments. In support of an induction site, tonsillar B cells were reported to proliferate and differentiate into antibody-forming cells after in vitro exposure to respiratory pathogens.21-24 Furthermore, tonsils were inductive sites for B cell responses after direct antigen stimulation.25 However, the initiation of immune responses, the dissemination of lymphocytes primed in the human NALT, and the nature of cytokine "help" provided by resident tonsillar T lymphocytes for B cell isotype differentiation all remain poorly defined. It is also unclear whether the epithelium of NALT represents an important site for cell-mediated immunity and cytotoxic T lymphocyte activity, as does its intestinal counterpart.18
In this study, we analyzed and compared functional characteristics of B and T cells in adenoids and tonsils to determine whether lymphoid cells in these organs display features associated with the systemic or mucosal compartments. For this purpose, B and T cell frequencies and the patterns of Ig isotypes and subclasses of Ig-producing cells were discerned in situ and in freshly dispersed or cultured mononuclear cells isolated from both adenoids and tonsils. The potential contribution of tonsillar T helper cell-derived cytokines to support immune responses in the respiratory tract was also addressed by the analysis of mitogen- and antigen-induced cytokine responses.
| Materials and Methods |
|---|
|
|
|---|
Twenty-four nasopharyngeal (adenoids) and 38 palatine tonsils (tonsils) were obtained from children or adolescents suffering from adenoid hypertrophy or recurrent tonsillitis who underwent adenoidectomy and/or tonsillectomy at the Vanderbilt University Childrens Hospital, Nashville, Tennessee. Fifteen tonsils were also obtained through the Tissue Procurement Core Facility at the University of Alabama at Birmingham (UAB). The study was carried out with full approval of the Human Use Committees at Vanderbilt University and UAB.
Mononuclear Cell Isolation
Adenoids and tonsils from Vanderbilt University were shipped overnight at 4°C in minimum essential medium (Gibco, BRL, Life Technologies, Grand Island, NY) supplemented with 200 U/ml penicillin, 200 µg/ml streptomycin, 1 µg/ml amphotericin B, 50 µg/ml gentamicin, and 290 µg/ml glutamine to the UAB Immunobiology Vaccine Center, where they were processed immediately. Tonsils obtained from the UAB Tissue Procurement Core Facility were processed within 3 hours after surgery. The organs were washed extensively in RPMI 1640 (Cellgro, Mediatech, Washington, DC) supplemented with 100 U/ml penicillin, 100 µg/ml streptomycin, and 2 µg/ml amphotericin B to prevent bacterial and fungal contamination. To isolate tonsillar intraepithelial lymphocytes (IELs), the specimens were incubated overnight on ice in 50-ml centrifuge tubes containing 40 ml of RPMI 1640 and 1 mg/ml of protease (Sigma-Aldrich Chemicals, St. Louis, MO). The tissues were then subjected to gentle agitation for 1 minute and supernatants were collected and stored at 4°C. Fresh medium was added to the tubes and the procedure was repeated 3 times. Hematoxylin and eosin staining of histological sections showed that this procedure removed the epithelial layer without affecting the crypts and the structure of the organs (data not shown). IELs were further purified in discontinuous Percoll gradients where they were collected at the 40 to 55% and 55 to 75% interfaces, as previously described.26 The subepithelial and germinal center mononuclear cells were obtained by mechanical dissociation of the remaining tonsillar tissues. The residual tissue was minced, teased, and passed through sterile wire mesh. The cell suspensions were washed twice before separation on Ficoll-Histopaque-1077 gradient (Sigma; 400 x g, 30 minutes at 20°C) to obtain mononuclear cells. The mononuclear cells were washed three times with RPMI 1640 medium supplemented with 10 mmol/L HEPES and 10% fetal calf serum (Atlanta Biologicals, Norcross, GA; complete medium) and their viability was assessed by trypan blue dye exclusion. The IEL preparations were 95 to 97% viable, whereas isolated tissue lymphoid cells were >99% viable.
Fluorescence-Activated Cell Sorter (FACS) Analysis
Mononuclear cells were stained with the following monoclonal
antibodies (mAbs): anti-CD3 (clone SK7), anti-CD4 (clone SK3), anti-CD8
(clone SK1), anti-T cell receptor (TCR)
ß (clone WT31),
anti-TCR 
(clone 11F2), anti-CD19 (clone 4G7), anti-HLA-DR (clone
L243), anti-CD14 (clone M[sws1]P9), anti-CD25 (clone 2A3), from
Becton Dickinson (San Jose, CA), and anti-CD28 (clone IOT28) from AMAC,
Inc. (Westbrook, ME). Staining of surface Ig was performed with
biotinylated anti-µ, -
, or -
antibodies obtained from Biosource
International (Camarillo, CA). Monoclonal antibodies (mAbs) to IgA1
(clone NI 512) and to IgA2 (clone NI 6911) subclasses were generously
provided by Dr. Jiri Mestecky at UAB and those for IgG subclasses
(clone HP 6012, HP 6014, HP 6047, and HP 6022 for IgG1, IgG2, IgG3, and
IgG4, respectively) were a gift of the Center for Disease
Control (Atlanta, GA). For flow cytometry analysis, cell
suspensions were incubated for 30 minutes on ice with the
appropriate fluorescent labeled mAbs or with biotinylated mAbs,
followed by staining with fluorescein isothiocyanate (FITC)-conjugated
streptavidin (PharMingen, San Diego, CA). Cells were then washed
extensively and analyzed by flow cytometry using a FACScan (Becton
Dickinson).
Immunohistochemistry
The phenotypes of lymphoid cells in the intraepithelial and
subepithelial compartments of adenoids and tonsils, as well as the
patterns of surface Ig isotypes, were also analyzed on tissue sections.
For this purpose, 4-µm paraffin sections of adenoids and tonsils were
deparaffinized, rehydrated, and stained with the following biotinylated
mAbs to determine the tissue distribution of T cells (anti-CD3; clone
SK7), B cells (anti-CD20; clone L26; Becton Dickinson), and
monocytes/macrophages (anti-CD66, clone KP1; Dako, Carpinteria, CA).
Furthermore, anti-µ, -
, and -
Abs (Biosource International) and
the anti-IgA subclass
1 (clone NI 512) and
2 (clone NI 6911)
mAbs described above were used to determine the relative numbers of Ig
isotype and IgA subclass positive cells in situ. When
sections were stained for IgA and one IgA subclass, the two images were
merged by use of Adobe Photoshop (Adobe Systems, Inc., San Jose, CA).
Detection of Ig-Secreting Cells by Enzyme-Linked Immunospot Assay (ELISPOT)
Frequencies of B cells secreting IgM, IgG, and IgA as well as the
subclasses IgG1, IgG2, IgG3, IgG4, IgA1, and IgA2 in adenoids and
tonsils were evaluated by a modified solid phase ELISPOT on microtiter
plates with nitrocellulose filters.27
Briefly, the
nitrocellulose-based wells (Millipore Corp., Bedford, MA) were coated
with the F(ab')2 fragment of goat anti-human
antibodies to µ,
, or
chains (Jackson ImmunoResearch Inc.,
West Grove, PA). For IgA subclasses, the
1 mAb (clone NI 512) and
2 mAb (clone NI 6911) were used as described above. The mAbs were
diluted in phosphate-buffered saline (PBS) and incubated overnight at
4°C. After blocking and washing, serial dilutions of cells were
distributed to duplicate wells and incubated for 4 hours at 37°C in a
humid atmosphere of 5% CO2. The anti-µ,
-
, and -
Abs for detecting IgM, IgG, and IgA, as well as the mAbs
specific for IgG- and IgA-subclasses described above, were used in this
assay. After addition of appropriate Ab, horseradish peroxidase
(HRP)-conjugated avidin (Gibco), was added, followed by HRP-conjugated
goat anti-mouse IgG1 Ab (Southern Biotechnology Associates, Birmingham,
AL). Finally, the peroxidase substrate 3-amino-9-ethylcarbazole
(AEC) (Moss Inc., Pasadena, MD) was added to plates and
Ig-secreting cells (IgSCs) were counted with the aid of a dissecting
microscope (SZH Zoom Stereo Microscope System, Olympus, Lake Success,
NY). To confirm that we were evaluating active Ig secretion and not
cytophilic Ig binding to cells with subsequent passive release, an
aliquot of each cell preparation was treated with 2 mmol/L
cycloheximide 2 hours before and during the incubation period. This
treatment inhibited by >90% the numbers of IgSCs.
Lymphoproliferative Responses
Mononuclear cells (2 x 105 to 4 x 105/well) were cultured in complete medium in 96-well flat bottom plates (Costar Corp., Cambridge, MA). Mitogen stimulation of T cells was performed with 5 µg/ml of phytohaemagglutinin (PHA; Murex Diagnostics Limited, Dartford, UK). For antigen-specific proliferative assays, cells were cultured with soluble Candida albicans antigen (20 µg/ml; Greer Laboratories, Lenoir, NC), UV-inactivated influenza virus (Wt A/Beijing, H3N2; 1.02 x 104 HAU/ml), tetanus toxoid (TT; kindly provided by Dr. Masahiko Mutai, Biken Research Foundation, Osaka University), or diphtheria toxoid (DT; kindly provided by Dr. Freda Pietrobon, Connaught Laboratories, Swiftwater, PA) coated to beads28,29 at a 10:1 bead:cell ratio. Cells were cultured for 72 hours with mitogen or for 5 days with antigen, and the proliferative responses were determined by the levels of tritiated [3H]thymidine (0.5 µCi/well; Amersham Corp., Arlington Heights, IL) incorporated by cells during the last 18 hours of cell culture.
Cytokine Assessment
Cytokine levels in culture supernatants were determined by
enzyme-linked immunosorbent assay (ELISA) using the following mAbs for
coating: mouse anti-human interleukin (IL)-4 (8D48), rat anti-human
IL-5 (TRFK5), rat anti-human IL-10 (JES39D7), mouse anti-human IL-12
(C8.3) and mouse anti-human tumor necrosis factor (TNF)-
mAb
(PharMingen); mouse anti-human interferon (IFN)-
(B-B1; Biosource
International) and chicken anti-human transforming growth factor
(TGF)-ß (AB-101-NA; R&D Systems, Minneapolis, MN). Nunc-Immuno plates
with a MaxiSorp surface (NalgeNunc, Nasperville, IL) were coated with
100 µl of the appropriate dilution of anti-cytokine antibody in PBS
and incubated overnight at 4°C. The wells were blocked with PBS
containing either 1% bovine serum albumin or 1% dry milk (for
IFN-
) at 25°C for 1 to 2 hours. Serial twofold dilutions of
supernatants were added into duplicate wells and incubated overnight at
4°C. For the analysis of TGF-ß, samples were incubated with 1 N HCl
for 1 hour at 37°C to activate the TGF-ß and the pH neutralized
before addition of samples to plates. The plates were next washed and
incubated with the following mAbs: rat anti-human IL-4 (MP425D2), rat
anti-human IL-5 (JES15A10), rat anti-human IL-10 (JES312G8), mouse
anti-human TNF-
(MAß11), mouse anti-human IL-12 (C8.6)
(PharMingen); rabbit anti-human IFN-
(P-700; Endogen, Woburn, MA);
anti-human TGF-ß (80-1835-03; Genzyme Corp., Cambridge, MA) diluted
in PBS-T containing 1% bovine serum albumin for 1 to 2 hours at
25°C. Finally, HRP-conjugated avidin (Gibco) was added for IL-4,
IL-5, IL-10, IL-12, TGF-ß, and TNF-
, and goat anti-rabbit IgG HRP
conjugate (Southern Biotechnology Associates) was used for assessment
of IFN-
. Standard curves were generated for each cytokine assay with
recombinant human cytokines (PharMingen). The ELISA assays were capable
of detecting 25 pg/ml of IFN-
, TNF-
, IL-4, IL-5, IL-10,
and IL-12, and 400 pg/ml of TGF-ß.
Statistics
The results are expressed as the mean ± SD. Statistical significance (P < 0.05) was analyzed by the Students t-test and by analysis of variance followed by the Fisher least significant difference test. The results were analyzed using the Statview II statistical program (Abacus Concepts, Berkeley, CA) adapted for MacIntosh computers.
| Results |
|---|
|
|
|---|
Flow cytometry analysis of mononuclear cells present in the
subepithelial compartment of adenoids and tonsils revealed that 25 to
35% were CD3+ T cells, 60 to 75% were
CD19+ B cells, and 5 to 8% were
M13+ macrophages (Figure 1)
. Comparison of cells from adenoids and
tonsils showed higher percentages of B cells (P
< 0.05) in tonsils (76%) than in adenoids (64%; Figure 1
). When
cells isolated from the intraepithelial compartment of tonsils were
analyzed, we noted a similar distribution pattern of B cells, T cells,
and macrophages as tonsillar subepithelial mononuclear cells (Figure 1)
. However, the relative numbers of T cells were somewhat higher
(P < 0.05) in the epithelium. We also confirmed
this pattern of cell subsets in fixed sections of adenoid tissue, where
B cells were again predominant (Figure 2)
. As shown in the
inset of Figure 2, B
cells were also the major lymphocyte population in
the epithelium of adenoids.
|
|
Analysis of surface Ig-positive (sIg+) B
cells revealed comparable numbers of both adenoids and tonsils where
sIgM+ was the predominant B cell type, followed
by sIgG+ and sIgA+ B cells
(Table 1)
. IgA subclass analysis showed
that >90% of sIgA+ B cells in both tissues were
IgA1+ (Table 1)
. We also investigated whether
this pattern of sIg expression reflected functional B cell responses by
analyzing the frequencies of B cells spontaneously secreting Ig
(Ig-secreting cells; IgSCs). Despite individual variations in the total
numbers of IgSCs, the Ig isotype- and subclass-specific ELISPOT assays
showed a similar distribution of IgG > IgM > IgA IgSCs
among different subjects and among autologous adenoid and tonsil
mononuclear cell or IEL isolates (Figure 3A)
. Indeed, the IgSCs of IgG isotype
accounted for the majority of the IgSCs (approximately 65%) in both
adenoids and tonsils, followed by IgM (2530%) and IgA (710%).
Interestingly, this same distribution of IgSCs was observed in
mononuclear cells isolated from the intraepithelial compartment of
tonsils (Figure 3A)
. One may argue that the enzymatic method used in
cell isolation could affect the frequency of IgSCs detected. To confirm
that this was not the case, we next assessed IgG- and IgA-positive
cells in paraffin sections of adenoids and tonsils. As expected, higher
numbers of IgG+ than IgA+ B
cells were observed in paraffin sections (Figure 3B)
.
|
|
We further assessed B cell responses in these tissues by
analyzing IgG- and IgA-subclass-specific IgSCs in subepithelial
mononuclear cells and tonsillar IELs by ELISPOT assay. These
experiments revealed that IgG1 was the predominant IgG subclass in both
adenoids and tonsils followed by IgG3, IgG2, and IgG4
antibody- forming cells (Figure 4A)
.
The IgA subclass-specific ELISPOT revealed that both adenoid and
tonsillar mononuclear cells secreted almost exclusively IgA1 Abs
(Figure 4B)
. The latter observation was consistent with the prevalence
of IgA1+ B cells in adenoids and tonsils in
situ (Figure 4C)
.
|
The T cell subsets present in adenoids and tonsils were determined
by FACS analysis before functional studies. The majority of T cells
(8090%) in these tissues were CD4+ (Table 2)
. In general, adenoid mononuclear cells
contained higher numbers of CD4+ T cells than
their tonsillar counterpart. No differences were observed in the
frequency of CD8+ T cells between the two
tissues. Most of the T cells possessed the
ß TCR and only 2 to 3%
of the mononuclear cells expressed the 
TCR (Table 2)
. The CD25
molecule, which characterizes activated cells, was also expressed by
cells from both adenoids and tonsils with higher levels
(P < 0.05) in adenoids when compared with
tonsils (Table 2)
. The CD28 molecule was expressed by virtually all
tonsillar and adenoid CD3+ T cells (Table 2)
.
Tonsillar IELs contained more T cells than subepithelial mononuclear
cells isolated from the same tissue. In fact, tonsillar IELs resembled
adenoid mononuclear cells based on the pattern of T cell subsets and
activation markers expressed.
|
We next measured proliferative responses and
cytokine synthesis in response to diphtheria toxoid (DT), tetanus
toxoid (TT), influenza virus, or C. albicans
anti- gens. We assumed that the subjects had either been
vaccinated with these antigens or were exposed to them through
infection. Only 8 of 24 adenoids and 10 of 53 tonsils examined
responded to DT, TT, or influenza virus antigens. In contrast,
responses to C. albicans were observed in 85 to 90% of all
samples tested. Furthermore, adenoid and tonsil T cells generally
exhibited low responses to DT, TT, or influenza antigens (stimulation
index (SI) = 2.73.6), whereas C. albicans
stimulation consistently resulted in higher proliferative responses
(SI = 5.79.1). No significant difference was noted between
proliferative responses of paired adenoids and tonsils (Figure 5)
or when tonsillar subepithelial
mononuclear cells were compared with tonsillar IELs (data not shown).
|
(Figure 5)
secretion was detected in the absence of significant
3[H]-thymidine uptake. In contrast, no IL-4 was
detected in culture supernatants of adenoid or tonsil mononuclear cells
after antigen stimulation (Figure 5)
or IL-5. Furthermore, IFN-
secretion was
occasionally enhanced in culture supernatants in the absence of
detectable proliferative responses. Mitogen-Induced Cytokine Responses by Adenoid and Tonsillar Lymphocytes
Because IFN-
and IL-5 were the only cytokines detected in
culture supernatants of antigen-stimulated adenoid and tonsillar
mononuclear cells, it was important to determine whether these cells
possessed the potential to secrete additional Th1- and Th2-type
cytokines. We next assessed cytokine profiles after stimulation with
PHA. Significant individual variation was observed when paired adenoid
and tonsillar cells were stimulated for 72 hours with PHA and
stimulation indices (cpm PHA/cpm unstimulated; SI) of responding
samples ranged from 10 to 64.
When Th1- and Th2-type cytokines were assessed, Th1- (ie, IFN-
) and
Th2- (IL-4, -5, and -10) type cytokines were induced in cell cultures
of both low and high responder populations after mitogenic stimulation
with PHA. Interestingly, culture supernatants from low responder
cultures contained higher levels of IFN-
(Th1-type) when compared
with Th2-type cytokines (Figure 6A)
,
whereas the opposite was noted in high responder cell cultures (Figure 6B)
. Both low and high responder adenoid and tonsillar mononuclear
cells actively secreted TNF-
and TGF-ß (Figure 6)
, but not IL-12
(data not shown).
|
| Discussion |
|---|
|
|
|---|
Different Ig isotypes possess characteristic effector functions and may dominate a particular antigen-specific Ab responses in a defined environment.31 In this regard, either predominant systemic or mucosal immunity is usually reflected by the ratio of IgG and IgA Abs, because the IgA isotype predominates in mucosal areas,32,33 whereas IgG provides significant systemic protection.31 Furthermore, IgA2 Abs increase in the large intestine and genitourinary tracts, whereas IgA1 antibodies are prevalent in other mucosal effector sites.34-37 In our study, adenoid and tonsillar mononuclear cells did not differ in distribution of T and B cells, supporting previous reports where the two organs were shown to share similar distributions of lymphocyte populations.4,11,38 We also provide new evidence that, despite a similar pattern of lymphoid cell distribution, the tonsils contain more B cells than the adenoids. Interestingly, in contrast to the mucosal surfaces of the GI tract where T cells usually occur, B cells were the predominant lymphocyte present in both the subepithelial and intraepithelial compartments of tonsils. These observations and the predominance of IgG- versus IgA-secreting cells in both adenoids and tonsils suggest that the MALT is diverse and exhibits different patterns of T cell and B cell Ig isotype responses. In this regard, human adenoids and tonsils contain more IgG secreting cells than does the lamina propria of the GI tract, where the majority of B cells secrete IgA.27,32 Although the proportion of B and T cells in adenoids and tonsils resemble that of Peyers patches in the intestine, B cells in the latter organ primarily secrete IgA, followed by IgM and IgG.27,32 Thus, when compared to inductive (ie, Peyers patches) or effector (ie, lamina propria) sites of the GI tract, adenoids and tonsils should be classified as non-classical mucosal inductive sites. However, the localization of IgA- and large numbers of IgG-secreting cells in the epithelium and subepithelial compartments suggests that the adenoids and tonsils have characteristics of effector sites and that IgG could be a significant component of mucosal immune responses in these tissues. Murine NALT, on the other hand, which is often compared with tonsils and adenoids, has been shown to contain equal numbers of B and T cells,39,40 whereas Peyers patches in the GI tract are enriched in B cells, although significant numbers of T cells are also present. It has also been shown that murine NALT, like Peyers patches, contain approximately threefold higher numbers of CD4+ than CD8+ T cells.18,41 Our studies suggest that adenoids and tonsils resemble murine Peyers patches in terms of B and T cell subsets. However, in contrast to murine Peyers patches, human adenoids and tonsils are primed for higher IgG than IgA responses. Although NALT, like Peyers patches, was shown to produce more IgA than IgG,42 there are also reports suggesting that NALT produces more IgG than IgA.40,43 In this study, we have shown that both adenoids and tonsils produced more IgG than IgA, supporting a role for IgG in the protection of mucosal surfaces of the upper respiratory tract.
The patterns of human IgA and IgG subclasses are influenced by the nature of the antigens they encounter. Protein antigens generally stimulate IgG1 and IgG3 subclasses, whereas bacterial polysaccharides and lipopolysaccharides induce IgG2 as the predominant subclass, and parasites or chronic antigenic exposure is often associated with IgG4 antibodies.31,44 The IgA1 Abs are generally induced by protein antigens, whereas polysaccharides, lipopolysaccharides, and lipoteichoic acid stimulate the IgA2 subclass.45-47 In our study, both adenoids and tonsils showed a pattern of IgG subclass responses consisting primarily of IgG1 followed by IgG3 Abs. We also found that these tissues contained almost exclusively IgA1 Abs. These observations indicate that both tissues are exposed to the same environment and interact primarily with protein antigens. Further, the predominance of IgA1 subclass-secreting cells in both adenoids and tonsils is consistent with the prevalence of IgA1 Abs in the upper respiratory tract and sets these organs apart from effector sites in the large intestine and genitourinary tracts, which contain higher proportions of IgA2 Abs.33-37
The ability of adenoid and tonsillar mononuclear cells to respond to antigens is poorly documented and, to our knowledge, no study has directly compared these two tissues. We used four recall antigens to stimulate adenoid and tonsillar cultures assuming that subjects were either systemically vaccinated (eg, TT, DT, and influenza virus) or naturally exposed (eg, C. albicans or influenza virus) to them and thus would possess antigen-specific (memory) lymphocytes. Further, it has been reported that NALT T cells respond to recall antigens for up to 6 months after the initial immunization,38 thus suggesting that adenoids and tonsils retain memory cells. Both adenoid and tonsillar mononuclear cells proliferated in response to recall antigens from pathogens with tropism for the upper respiratory tract (eg, C. albicans and influenza virus). Interestingly, they also responded to antigens like TT, which are typical of systemic vaccination, suggesting that adenoids and tonsils are also effector sites for at least some immune responses initiated in the systemic compartment. In our study, approximately 80 to 90% of subjects responded to C. albicans, whereas fewer samples responded to DT, TT, or influenza virus. These results are consistent with the limited ability of human adenoid cells to undergo clonal expansion after antigenic stimulation.24 Indeed, stimulation of adenoid lymphocytes with influenza virus was low in both seronegative and seropositive donors,24 suggesting that NALT sites are more prone to B than to T cell responses. In this regard, in vitro stimulation of cells from seropositive donors with wild-type influenza virus resulted in secretion of influenza-specific antibodies, whereas low proliferative responses occurred.24 However, the higher percentage of subjects responding to C. albicans suggests that the potential of adenoid and tonsillar cells to respond to an antigen may depend on the nature of antigen and the extent of previous exposure. Thus, vaccination of patients before they undergo tonsillectomy would allow a precise analysis of vaccine-specific responses of adenoid and tonsillar T cells.
Antigen stimulation of tonsillar and adenoid cells in vitro
resulted in enhanced IFN-
production, whereas secretion of IL-5 was
seen in response to C. albicans and less frequently in
response to other recall antigens. IFN-
has been reported to
stimulate the growth and differentiation of Ig-secreting tonsillar B
cells.48
On the other hand, IL-5 was shown to augment IgM
secretion by human B cells.49
We also noted that
PHA-stimulated tonsillar and adenoid cells secreted additional Th2-type
cytokines (ie, IL-4 and -10) that support Ab responses.
Furthermore, TNF-
and other inflammatory cytokines have been shown
to support the clonal expansion of antigen-activated
CD4+ T cells and to provide help for
antigen-specific Ab responses.50
Interestingly, mitogen
stimulation of adenoid and tonsillar mononuclear cells resulted in high
levels of TNF-
synthesis, suggesting that this molecular pathway may
support Ab responses in vivo when NALT sites are exposed to
appropriate immunogens. Our results of cytokine responses after antigen
stimulation are consistent with previous findings where peripheral
blood mononuclear cells from TT-vaccinated51
and
normal donors52
were shown to secrete IFN-
following
in vitro stimulation with TT or C. albicans,
respectively. Thus, similar patterns of antigen-specific cytokine
profiles may occur in both human peripheral blood mononuclear cells and
NALT (adenoids and tonsils) compartments. Our findings also suggest
that cytokine help provided by resident adenoid and tonsillar T
lymphocytes for B cell responses is similar to that of murine NALT
where a Th0 environment occurs.41
We have shown that, unlike murine NALT but similar to Peyers patches, mononuclear cells from adenoids and tonsils are predominantly B cells. However, in contrast to the small intestine and other mucosal effector sites, these two tissues contain more IgG- than IgA-producing cells. This distribution of B cell subsets may play an important role in the protection of the upper respiratory tract. The almost exclusive expression of IgA1 and the pattern of IgG subclass characterized by IgG1 and IgG3 identify these two tissues as distinct from mucosal immune compartments in the GI and genitourinary tracts and suggest that they respond to predominantly protein antigens in vivo. We have also shown that the human NALT displays a CD4+/CD8+ T cell ratio similar to the murine Peyers patches. Further, both NALT and Peyers patches provide a Th0 environment for B cell responses. Taken together, our findings show major similarities between adenoids and tonsils and suggest that these strategically placed tissues could play a role as inductive sites for nasal vaccines as well as effector sites for both IgG and IgA antibody responses.
| Acknowledgements |
|---|
| Footnotes |
|---|
Supported by National Institute of Allergy and Infectious Diseases Respiratory Pathogens Research Unit contract NO1 AI 65298, and by National Institutes of Health grants AI 43197, AI 18958 DE 12242, and DK 44240.
P. N. B., P. F. W., and M. M. contributed equally to this paper.
Current address for M. M. and S. Di F.: Istituto Superiore di Sanita, Rome, Italy.
Current address for H. F. S.: Center for AIDS Research, Duke University, Durham, NC.
Accepted for publication September 12, 2000.
| References |
|---|
|
|
|---|
in human B cell activation, growth and differentiation. Eur J Immunol 1986, 16:925-932[Medline]
This article has been cited by other articles:
![]() |
S. Mizrahi, E. Yefenof, M. Gross, P. Attal, A. Ben Yaakov, D. Goldman-Wohl, B. Maly, N. Stern, G. Katz, R. Gazit, et al. A phenotypic and functional characterization of NK cells in adenoids J. Leukoc. Biol., November 1, 2007; 82(5): 1095 - 1105. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhang, J. Bernatoniene, L. Bagrade, J. C. Paton, T. J. Mitchell, S. Hammerschmidt, D. A. Nunez, and A. Finn Regulation of Production of Mucosal Antibody to Pneumococcal Protein Antigens by T-Cell-Derived Gamma Interferon and Interleukin-10 in Children Infect. Immun., August 1, 2006; 74(8): 4735 - 4743. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q Zhang and A Finn Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria J. Clin. Pathol., October 1, 2004; 57(10): 1015 - 1021. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Davenport, T. Guthrie, J. Findlow, R. Borrow, N. A. Williams, and R. S. Heyderman Evidence for Naturally Acquired T Cell-Mediated Mucosal Immunity to Neisseria meningitidis J. Immunol., October 15, 2003; 171(8): 4263 - 4270. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhang, S. Choo, and A. Finn Immune Responses to Novel Pneumococcal Proteins Pneumolysin, PspA, PsaA, and CbpA in Adenoidal B Cells from Children Infect. Immun., October 1, 2002; 70(10): 5363 - 5369. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.J. Smith DENTAL CARIES VACCINES: PROSPECTS AND CONCERNS Critical Reviews in Oral Biology & Medicine, July 1, 2002; 13(4): 335 - 349. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |